Microfluidics in High-Throughput Drug Screening: Organ-on-a-Chip and C. elegans-Based Innovations

被引:7
|
作者
Yoon, Sunhee [1 ]
You, Dilara Kilicarslan [1 ]
Jeong, Uiechan [2 ]
Lee, Mina [1 ]
Kim, Eunhye [1 ]
Jeon, Tae-Joon [1 ,3 ,4 ]
Kim, Sun Min [1 ,2 ,4 ]
机构
[1] Inha Univ, Dept Biol Sci & Bioengn, Incheon 22212, South Korea
[2] Inha Univ, Dept Mech Engn, Incheon 22212, South Korea
[3] Inha Univ, Dept Biol Engn, Incheon 22212, South Korea
[4] Inha Univ, Biohybrid Syst Res Ctr BSRC, Incheon 22212, South Korea
来源
BIOSENSORS-BASEL | 2024年 / 14卷 / 01期
基金
新加坡国家研究基金会;
关键词
biochips; C; elegans; drug screening; microfluidics; cell chip; organ-on-a-chip; CAENORHABDITIS-ELEGANS; MODEL; CELL; DEVICES; PDMS; ABSORPTION; DISCOVERY; PLATFORM; NEURONS; DESIGN;
D O I
10.3390/bios14010055
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The development of therapeutic interventions for diseases necessitates a crucial step known as drug screening, wherein potential substances with medicinal properties are rigorously evaluated. This process has undergone a transformative evolution, driven by the imperative need for more efficient, rapid, and high-throughput screening platforms. Among these, microfluidic systems have emerged as the epitome of efficiency, enabling the screening of drug candidates with unprecedented speed and minimal sample consumption. This review paper explores the cutting-edge landscape of microfluidic-based drug screening platforms, with a specific emphasis on two pioneering approaches: organ-on-a-chip and C. elegans-based chips. Organ-on-a-chip technology harnesses human-derived cells to recreate the physiological functions of human organs, offering an invaluable tool for assessing drug efficacy and toxicity. In parallel, C. elegans-based chips, boasting up to 60% genetic homology with humans and a remarkable affinity for microfluidic systems, have proven to be robust models for drug screening. Our comprehensive review endeavors to provide readers with a profound understanding of the fundamental principles, advantages, and challenges associated with these innovative drug screening platforms. We delve into the latest breakthroughs and practical applications in this burgeoning field, illuminating the pivotal role these platforms play in expediting drug discovery and development. Furthermore, we engage in a forward-looking discussion to delineate the future directions and untapped potential inherent in these transformative technologies. Through this review, we aim to contribute to the collective knowledge base in the realm of drug screening, providing valuable insights to researchers, clinicians, and stakeholders alike. We invite readers to embark on a journey into the realm of microfluidic-based drug screening platforms, fostering a deeper appreciation for their significance and promising avenues yet to be explored.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Microfluidics and Organ-on-a-Chip for Disease Modeling and Drug Screening
    Nasiri, Rohollah
    Zhu, Yangzhi
    de Barros, Natan Roberto
    BIOSENSORS-BASEL, 2024, 14 (02):
  • [2] C. elegans in high-throughput drug discovery
    O'Reilly, Linda P.
    Luke, Cliff J.
    Perlmutter, David H.
    Silverman, Gary A.
    Pak, Stephen C.
    ADVANCED DRUG DELIVERY REVIEWS, 2014, 69 : 247 - 253
  • [3] A novel multicellular organ-on-a-chip platform for high-throughput screening of urothelial responses
    Kim, Hyeon Woo
    Park, So Jung
    Shin, Dong Gil
    Kim, Tae Nam
    Park, Chang-Ju
    Park, Yangkyu
    Seo, Seungwan
    Lee, Jeong Zoo
    JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2025, : 183 - 195
  • [4] High-throughput screening in the C. elegans nervous system
    Kinser, Holly E.
    Pincus, Zachary
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2017, 80 : 192 - 197
  • [5] Anti-MRSA agent discovery using Caenorhabditis elegans-based high-throughput screening
    Kim, Soo Min
    Escorbar, Iliana
    Lee, Kiho
    Fuchs, Beth Burgwyn
    Mylonakis, Eleftherios
    Kim, Wooseong
    JOURNAL OF MICROBIOLOGY, 2020, 58 (06) : 431 - 444
  • [6] Anti-MRSA agent discovery using Caenorhabditis elegans-based high-throughput screening
    Soo Min Kim
    Iliana Escorbar
    Kiho Lee
    Beth Burgwyn Fuchs
    Eleftherios Mylonakis
    Wooseong Kim
    Journal of Microbiology, 2020, 58 : 431 - 444
  • [7] A high-throughput behavioral screening platform for measuring chemotaxis by C. elegans
    Fryer, Emily
    Guha, Sujay
    Rogel-Hernandez, Lucero E.
    Logan-Garbisch, Theresa
    Farah, Hodan
    Rezaei, Ehsan
    Mollhoff, Iris N.
    Nekimken, Adam L.
    Xu, Angela
    Seyahi, Lara Selin
    Fechner, Sylvia
    Druckmann, Shaul
    Clandinin, Thomas R.
    Rhee, Seung Y.
    Goodman, Miriam B.
    PLOS BIOLOGY, 2024, 22 (06)
  • [8] Medium- and high-throughput screening of neurotoxicants using C. elegans
    Boyd, Windy A.
    Smith, Marjolein V.
    Kissling, Grace E.
    Freedman, Jonathan H.
    NEUROTOXICOLOGY AND TERATOLOGY, 2010, 32 (01) : 68 - 73
  • [9] High-throughput organ-on-a-chip systems: Current status and remaining challenges
    Probst, Christopher
    Schneider, Stefan
    Loskill, Peter
    CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2018, 6 : 33 - 41
  • [10] High-throughput sorting of eggs for synchronization of C. elegans in a microfluidic spiral chip
    Sofela, Samuel
    Sahloul, Sarah
    Rafeie, Mehdi
    Kwon, Taehong
    Han, Jongyoon
    Warkiani, Majid Ebrahimi
    Song, Yong-Ak
    LAB ON A CHIP, 2018, 18 (04) : 679 - 687